Eurofins Acquires Gene Synthesis Firm Entelechon | GenomeWeb

NEW YORK (GenomeWeb News) – Eurofins MWG Operon today announced it has acquired gene synthesis firm Entelechon for an undisclosed amount.

Entelechon was founded in 1999 in Regensburg, Germany, and focuses on genomics and proteomics projects "bringing broad experience in the fields of gene optimization and synthesis," Eurofins MWG Operon, the genomics division of Eurofins Scientific, said. The company serves the drug manufacturing industry as well as academic and public research institutes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic factors associated with facial features, a new mutation that makes individuals more prone to Brugada syndrome, and more.

Nutrigenomic companies offer gene-based diet advice, the Wall Street Journal reports.

Researchers have found a new kind of virus — one that starts out broken up into five parts.

Nature News explores the president's "science legacy."